Professor Ke Zhang is researching a new drug delivery method using oligonucleotides to treat Duchenne Muscular Dystrophy (DMD), with potential applications in other genetic diseases, offering hope for more efficient treatments.


Professor Ke Zhang is researching a new drug delivery method using oligonucleotides to treat Duchenne Muscular Dystrophy (DMD), with potential applications in other genetic diseases, offering hope for more efficient treatments.